METABOLISM OF N-(4-HYDROXYPHENYL)RETINAMIDE (4-HPR) IN HUMAN-BREAST TISSUES

被引：0
|
作者：
MEHTA, RG
COSTA, A
FORMELLI, F
MOON, RC
机构：
[1] IIT, RES INST, CHICAGO, IL 60616 USA
[2] IST NAZL TUMORI, I-20133 MILAN, ITALY
来源：
FASEB JOURNAL | 1988年 / 2卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1095 / A1095
页数：1
相关论文
共 50 条
  • [41] Upregulation of gadd153 expression in the apoptotic signaling of N-(4-hydroxyphenyl)retinamide (4HPR)
    Xia, Y
    Wong, NS
    Fong, WF
    Tideman, H
    INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (01) : 7 - 14
  • [42] Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesis
    Abou-Issa, H
    Curley, RW
    Alshafie, GA
    Weiss, KL
    Clagett-Dame, M
    Chapman, JS
    Mershon, SM
    ANTICANCER RESEARCH, 2001, 21 (6A) : 3839 - 3844
  • [43] N-(4-hydroxyphenyl)all-trans-retinamide (4-HPR) high dose effect on DMBA-induced hamster oral cancer: a histomorphometric evaluation
    Lajolo, C.
    Giuliani, M.
    Sgambato, A.
    Majorano, E.
    Lucchese, A.
    Capodiferro, S.
    Favia, G.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2008, 37 (12) : 1133 - 1140
  • [44] Results of experimental bioassays on the chemopreventive effects of vitamin A and N-(4-hydroxyphenyl)-retinamide (HPR) on mammary cancer
    Soffritti, M
    Mobiglia, A
    Pinto, C
    Bortoluzzi, L
    Lefemine, G
    Maltoni, C
    SCIENTIFIC BASES OF CANCER CHEMOPREVENTION, 1996, 1120 : 241 - 248
  • [45] Evidence of transforming growth factor-β (TGF-β) involvement in N-(4-hydroxyphenyl)retinamide (4-HPR)-induced apoptosis in human MDA-MB-435 breast cancer cells.
    Herbert, B
    Sanders, BG
    Kline, K
    FASEB JOURNAL, 1998, 12 (04): : A563 - A563
  • [46] N-(4-hydroxyphenyl) retinamide-induced apoptotic effects in human medulloblastoma
    Reedy, CD
    Guttapalli, A
    Vemuri, M
    Adamson, PC
    Sutton, LN
    Phillips, PC
    NEURO-ONCOLOGY, 2004, 6 (04) : 321 - 321
  • [47] COX-2 is essential for HER2/neu to suppress N(4-hydroxyphenyl)retinamide (4-HPR) apoptosis in breast cancer cells.
    Tari, A
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1343S - 1344S
  • [48] Induction of apoptosis and altered expression of PSA in 4-hydroxyphenyl retinamide (4-HPR)-treated LNCaP prostatic cells.
    Hsieh, TC
    Wu, JM
    FASEB JOURNAL, 1996, 10 (06): : 541 - 541
  • [49] Cytotoxic responses to N-(4-hydroxyphenyl)retinamide in human pancreatic cancer cells
    Maria C. Messner
    Myles C. Cabot
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 477 - 487
  • [50] N-(4-HYDROXYPHENYL) RETINAMIDE IS ANTICLASTOGENIC IN HUMAN LYMPHOBLASTOID CELL-LINES
    TRIZNA, Z
    BENNER, SE
    SHIRLEY, L
    FURLONG, C
    HONG, WK
    ANTICANCER RESEARCH, 1993, 13 (02) : 355 - 356
12345